Divozilimab (Anti-CD20)

Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.

• Supplier: Selleck Chemicals
• Product #: A2823
• Sku #: A2823-1mg*25